Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02147860 · ClinicalTrials.gov registry record · NA
Full Day and Night Closed-Loop With DiAs Platform
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT02147860 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 44 participants.
The verdict
NCT02147860, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The overall aim of this proposed research is to determine the safety, feasibility and efficacy of the Diabetes Assistant (DiAs) controller in day and night closed-loop control in children and adolescents with type 1 diabetes over multiple days in a diabetes camp setting. This will be addressed in two parts: 1) An in residence, outpatient study to determine safety and feasibility of the DiAs during 72 continuous hours of day and night glucose control; and 2) Camp studies planned for the summer of 2014 with randomization to either full closed-loop or sensor-augmented pump therapy over the duration of 6-7 day diabetes camps.
Interventions
- OTHER Sensor Augmented Pump Therapy
- DEVICE Diabetes Assistant (DiAs) with USS Virginia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02147860
The ClinicalTrials.gov registry entry for NCT02147860 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sensor Augmented Pump Therapy is the first listed.
NCT02147860 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02147860 about?
NCT02147860 is a clinical study titled "Full Day and Night Closed-Loop With DiAs Platform". The overall aim of this proposed research is to determine the safety, feasibility and efficacy of the Diabetes Assistant (DiAs) controller in day and night closed-loop control in children and adolescents with type 1 diabetes over multiple days in a diabetes camp setting. This will be addressed in tw...
What is the current status of trial NCT02147860?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2014-05. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02147860?
The interventions under investigation include: Sensor Augmented Pump Therapy (OTHER), Diabetes Assistant (DiAs) with USS Virginia (DEVICE).
Who is sponsoring clinical trial NCT02147860?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.